
    
      The purpose of this study is to evaluate the efficacy of combined intravesical therapy with
      hyaluronic acid and chondroitin sulphate(IARULIL®) in the treatment of recurrent cystitis
      refractory to oral Escherichia Coli extract(Uro-Vaxom®) and the change of urinary tract
      infection symptoms after intravesical instillation treatment with IARULIL®.
    
  